Crohn’s disease is a chronic inflammatory condition of the digestive (or gastrointestinal (GI)) tract that belongs to a group of conditions known as Inflammatory Bowel Diseases (IBD). Crohn’s affects 700,000 people in the US alone, targets men and women equally, and most often occurs in people between the ages of 15 and 35. The disease was described initially in 1932 by Dr. Burrill B. Crohn – for whom the condition was named.
HPC Specialty Pharmacy offers effective drug therapies for patients with Crohn’s disease. The HPC complete system of care is particularly important for chronic medical conditions such as Crohn’s, offering patients access to vital clinical and administrative services that are designed to monitor, support, and improve the medical outcomes of their therapy.
Crohn’s Types and Specialized Treatment
Crohn’s disease runs the gamut from mild to severe. A chronic illness, its diagnosis can be difficult because it often presents with symptoms that are similar to other IBD conditions. Crohn’s can affect any area of the GI tract and cause a range of symptoms from abdominal pain and fever to blockage of the intestines. Specific symptoms and complications are related to the part of the GI tract that is involved, and are what define the type of Crohn’s a patient has.
The cause of Crohn’s is not understood fully. One popular theory suggests that the body’s immune system mistakes harmless bacteria and food as harmful – triggering an immune response and inflammation. The inflammation does not subside, which causes symptoms.
Treatment for this condition includes diet, which can reduce symptoms and replace nutrients. As many as 70% of Crohn’s patients eventually will require surgery to remove diseased tissue and the associated symptoms, however, the disease can recur in these patients (30% within 3 years, 60% within 10 years).
Medications also are used to treat Crohn’s to suppress the body’s abnormal inflammatory response, decrease response frequency, and allow the body to heal. Drug types include anti-inflammation drugs, cortisone or steroids, and immunosuppressants.
Biologic response modifiers, or biologics, are the latest class of drug therapy which target TNF-a, IL-1, and IL-6 – the body’s main inflammatory-producing enzymes. HPC offers the following Biologic disease-modifying antirheumatic drugs (DMARDs) for the treatment of Crohn’s disease:
Your Partner for Care
Compliance with the medication treatment plan for Crohn’s is critical for inducing and maintaining its remission in patients.
HPC’s approach to delivering and administering the most advanced medications – combined with our comprehensive care system supports the best possible medical outcomes for our patients. Our coordination with the patient’s medical team and extensive clinical and administrative services provide care planning, collaboration, and monitoring that help ensure vital patient adherence to the therapy.
In addition, our home-based nursing staff is trained in administering therapies that require injections or IV infusion. HPC’s dedicated patient education services empower patients with important knowledge about their condition, their treatments, and the effective management of both.
For more information on Crohn’s & Colitis conditions, please visit the following sites: